SI
Sofinnova Investments’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.5M | Buy |
+293,661
| New | +$20.5M | 1.26% | 24 |
|
|
2025
Q1 | – | Sell |
-651,344
| Closed | -$42.7M | – | 65 |
|
|
2024
Q4 | $42.7M | Sell |
651,344
-158,062
| -20% | -$10.4M | 3.11% | 8 |
|
|
2024
Q3 | $63.1M | Buy |
809,406
+7,989
| +1% | +$622K | 5% | 4 |
|
|
2024
Q2 | $62.5M | Buy |
801,417
+204,704
| +34% | +$16M | 3.25% | 7 |
|
|
2024
Q1 | $40.4M | Sell |
596,713
-253,864
| -30% | -$17.2M | 2.25% | 14 |
|
|
2023
Q4 | $57.3M | Sell |
850,577
-512,259
| -38% | -$34.5M | 3.2% | 7 |
|
|
2023
Q3 | $92.3M | Sell |
1,362,836
-334,681
| -20% | -$22.7M | 5.82% | 3 |
|
|
2023
Q2 | $121M | Buy |
+1,697,517
| New | +$121M | 7.96% | 3 |
|
|
2023
Q1 | – | Sell |
-613,673
| Closed | -$41.6M | – | 51 |
|
|
2022
Q4 | $41.6M | Sell |
613,673
-88,205
| -13% | -$5.98M | 2.47% | 11 |
|
|
2022
Q3 | $38.5M | Buy |
701,878
+385,518
| +122% | +$21.1M | 2.24% | 9 |
|
|
2022
Q2 | $20.9M | Sell |
316,360
-237,543
| -43% | -$15.7M | 1.74% | 14 |
|
|
2022
Q1 | $36.7M | Buy |
+553,903
| New | +$36.7M | 2.79% | 7 |
|
|
2021
Q4 | – | Sell |
-1,128,272
| Closed | -$67.8M | – | 65 |
|
|
2021
Q3 | $67.8M | Buy |
1,128,272
+168,640
| +18% | +$10.1M | 4.01% | 5 |
|
|
2021
Q2 | $57.5M | Sell |
959,632
-76,100
| -7% | -$4.56M | 3.31% | 6 |
|
|
2021
Q1 | $51.5M | Buy |
1,035,732
+193,132
| +23% | +$9.6M | 3.1% | 6 |
|
|
2020
Q4 | $42.1M | Buy |
+842,600
| New | +$42.1M | 2.51% | 7 |
|
|
2019
Q2 | – | Sell |
-261,577
| Closed | -$10.6M | – | 65 |
|
|
2019
Q1 | $10.6M | Sell |
261,577
-54,751
| -17% | -$2.21M | 1.02% | 18 |
|
|
2018
Q4 | $12M | Buy |
316,328
+75,720
| +31% | +$2.88M | 1.5% | 17 |
|
|
2018
Q3 | $9.52M | Sell |
240,608
-89,192
| -27% | -$3.53M | 0.85% | 22 |
|
|
2018
Q2 | $11.6M | Buy |
329,800
+307,968
| +1,411% | +$10.8M | 1.31% | 18 |
|
|
2018
Q1 | $763K | Buy |
+21,832
| New | +$763K | 0.13% | 23 |
|